If you made any changes in Pure these will be visible here soon.

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2008 2019

Addition of a 161-SNP polygenic risk score to family history-based risk prediction: Impact on clinical management in non- BRCA1/2 breast cancer families

Lakeman, I. M. M., Hilbers, F. S., Rodríguez-Girondo, M., Lee, A., Vreeswijk, M. P. G., Hollestelle, A., Seynaeve, C., Meijers-Heijboer, H., Oosterwijk, J. C., Hoogerbrugge, N., Olah, E., Vasen, H. F. A., van Asperen, C. J. & Devilee, P., 2019, In : Journal of Medical Genetics.

Research output: Contribution to journalArticleAcademicpeer-review

Direct-to-consumer carrier screening for cystic fibrosis via a hospital website: a 6-year evaluation

Holtkamp, K. C. A., Henneman, L., Gille, J. J. P., Meijers-Heijboer, H., Cornel, M. C. & Lakeman, P., 4 Apr 2019, In : Journal of Community Genetics. 10, 2, p. 249-257

Research output: Contribution to journalArticleAcademicpeer-review

Height and Body Mass Index as Modifiers of Breast Cancer Risk in BRCA1/2 Mutation Carriers: A Mendelian Randomization Study

Qian, F., Wang, S., Mitchell, J., McGuffog, L., Barrowdale, D., Leslie, G., Oosterwijk, J. C., Chung, W. K., Evans, D. G., Engel, C., Kast, K., Aalfs, C. M., Adank, M. A., Adlard, J., Agnarsson, B. A., Aittomäki, K., Alducci, E., Andrulis, I. L., Arun, B. K., Ausems, M. G. E. M. & 39 othersAzzollini, J., Barouk-Simonet, E., Barwell, J., Belotti, M., Benitez, J., Berger, A., Borg, A., Bradbury, A. R., Brunet, J., Buys, S. S., Caldes, T., Caligo, M. A., Campbell, I., Caputo, S. M., Chiquette, J., Claes, K. B. M., Margriet Collée, J., Couch, F. J., Coupier, I., Daly, M. B., Davidson, R., Diez, O., Domchek, S. M., Donaldson, A., Dorfling, C. M., Eeles, R., Feliubadaló, L., Foretova, L., Meijers-Heijboer, H. E. J., van Engelen, K., HEBON, EMBRACE, GEMO Study Collaborators, Greene, M. H., Antoniou, A. C., Goldgar, D. E., Olopade, O. I., Rebbeck, T. R. & Huo, D., 1 Jan 2019, In : Journal of the National Cancer Institute. 111, 4, p. 350-364

Research output: Contribution to journalArticleAcademicpeer-review

Mendelian randomisation study of height and body mass index as modifiers of ovarian cancer risk in 22,588 BRCA1 and BRCA2 mutation carriers

Qian, F., Rookus, M. A., Leslie, G., Risch, H. A., Greene, M. H., Aalfs, C. M., Adank, M. A., Adlard, J., Agnarsson, B. A., Ahmed, M., Aittomäki, K., Andrulis, I. L., Arnold, N., Arun, B. K., Ausems, M. G. E. M., Azzollini, J., Barrowdale, D., Barwell, J., Benitez, J., Białkowska, K. & 34 othersBonadona, V., Borde, J., Borg, A., Bradbury, A. R., Brunet, J., Buys, S. S., Caldés, T., Caligo, M. A., Campbell, I., Carter, J., Chiquette, J., Chung, W. K., Claes, K. B. M., Collée, J. M., Collonge-Rame, M-A., Couch, F. J., Daly, M. B., Delnatte, C., Diez, O., Domchek, S. M., Dorfling, C. M., Eason, J., Easton, D. F., Eeles, R., Engel, C., Evans, D. G., Faivre, L., Meijers-Heijboer, H. E. J., Oosterwijk, J. C., van Engelen, K., EMBRACE Collaborators, KConFab Investigators, GEMO Study Collaborators & HEBON Investigators, 16 Jul 2019, In : British Journal of Cancer. 121

Research output: Contribution to journalArticleAcademicpeer-review